ask="3.18"
ask_size="2100"
average_daily_volume="4138610"
bid="3.15"
bid_size="100"
book_value="-1.75"
change="+0.10"
change_from_200_day_moving_average="-1.92"
change_from_50_day_moving_average="-1.01"
change_from_52_week_high="-5.82"
change_From_52_week_low="0.37"
change_in_percent="+3.23%"
close="3.20"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.37"
ebitda="-120.56M"
eps_estimate_current_year="-1.16"
eps_estimate_next_quarter="-0.10"
eps_estimate_next_year="-0.23"
ex_dividend_date="N/A"
float_shares="122562000"
high="3.23"
high_52_weeks="9.02"
last_trade_date="1/25/2017"
last_trade_price="3.20"
last_trade_size="35955"
last_trade_time="4:00pm"
low="3.06"
low_52_weeks="2.83"
market_capitalization="414.77M"
moving_average_200_day="5.12"
moving_average_50_day="4.21"
name="Merrimack Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="9.00"
open="3.11"
pe_ratio="N/A"
peg_ratio="-0.46"
percent_change_from_200_day_moving_average="-37.52%"
percent_change_from_50_day_moving_average="-24.05%"
percent_change_from_52_week_high="-64.50%"
percent_change_from_52_week_low="+13.07%"
previous_close="3.10"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="3.85"
revenue="104.45M"
shares_outstanding="129615000"
short_ratio="14.12"
stock_exchange="NGM"
symbol="MACK"
volume="2757719"
weeks_range_52="2.83 - 9.02"
